Cargando…
Targeted Therapies in Adult B-Cell Malignancies
B-lymphocytes are programmed for the production of immunoglobulin (Ig) after antigen presentation, in the context of T-lymphocyte control within lymphoid organs. During this differentiation/activation process, B-lymphocytes exhibit different restricted or common surface markers, activation of cellul...
Autor principal: | Rossi, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575712/ https://www.ncbi.nlm.nih.gov/pubmed/26425544 http://dx.doi.org/10.1155/2015/217593 |
Ejemplares similares
-
Targets for Ibrutinib Beyond B Cell Malignancies
por: Berglöf, A., et al.
Publicado: (2015) -
NF-κB in Hematological Malignancies
por: Imbert, Véronique, et al.
Publicado: (2017) -
XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy
por: Camus, Vincent, et al.
Publicado: (2017) -
Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
por: Shah, Nirav N., et al.
Publicado: (2019) -
Targeting CD22 for the Treatment of B-Cell Malignancies
por: Shah, Nikesh N, et al.
Publicado: (2021)